Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTION trial of indobufen versus aspirin after drug-eluting coronary stent implantation
ChiCTR-IIR-17013505Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in coronary arteriosclerosis comparing Indobufen + Clopidogrel with Aspirin + Clopidogrel (2 arms). Primary endpoints: Cardiac death, Non-fatal myocardial infarction and 2 more. Started Sep 2017; status: recruiting.
02
Drugs
Indobufenaspirinclopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-IIR-17013505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17013505.